These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 172853)

  • 1. Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test.
    Gershon AA; Krugman S
    Pediatrics; 1975 Dec; 56(6):1005-8. PubMed ID: 172853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life.
    Gershon AA; Raker R; Steinberg S; Topf-Olstein B; Drusin LM
    Pediatrics; 1976 Nov; 58(5):692-6. PubMed ID: 185578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA).
    Baba K; Yoshida M; Tawa A; Yabuuchi H; Maeda K; Takahashi M
    Biken J; 1984 Mar; 27(1):23-9. PubMed ID: 6091617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
    Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
    J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.
    Steele RW; Coleman MA; Fiser M; Bradsher RW
    Pediatrics; 1982 Oct; 70(4):604-8. PubMed ID: 6289236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
    Nyerges G; Mészner Z; Simon M
    Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
    Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of varicella zoster virus in pregnant patients].
    Sauerbrei A; Sonntag S; Wutzler P
    Zentralbl Gynakol; 1990; 112(4):223-6. PubMed ID: 2159681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.
    Gallo D; Schmidt NJ
    J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of antibody formation in intrauterine varicella virus infection.
    Trlifajová J
    Acta Virol; 1991 May; 35(3):295-7. PubMed ID: 1683137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.